A phase I study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women with breast cancer

Category Primary study
JournalJournal of Clinical Oncology
Year 2009
This article has no abstract
Epistemonikos ID: 489c9198e027616e1921a9b0900f2077a243eae1
First added on: Mar 01, 2025